Their own payment-practices filing · gov.uk
Cell Therapy Catapult Limited pays suppliers in 15 days on average — inside its 30-day stated terms
Their H1 2026 filing puts the average 15 days inside their stated 30-day term.
- Their stated terms
- 30 days
- Paid outside agreed terms
- 2% of invoices
- Paid after 61+ days
- 1%
- Reporting period
- 1 Oct 2025 – 31 Mar 2026
- Source
- their gov.uk filing, filed 29 Apr 2026
Self-reported figures from their statutory filing. How this is compiled.
Terms vs reality · their H1 2026 filing
Paid 15 days inside the 30-day term they state
Where their invoices landed · share of all invoices
The pattern · last 6 of 10 reports
Holding steady around 15 days
The read · computed from their figures
Cell Therapy Catapult Limited's H1 2026 filing puts their average at 15 days against stated terms of 30 days; 2% of invoices were paid outside agreed terms and 1% took 61 days or longer. Filed 29 Apr 2026.
The pattern is steady — their reported average moves within about ±1 days period to period.
On the latest reported averages: Faster than 89% of the 510 large companies reporting in professional & technical services.
That is 10 statutory periods on record (earliest H2 2021) — a historical record, not a promise for a new invoice.
In their own words · from the filing
Standard payment terms
Net 30 days from invoice date
Dispute resolution
There is a generic email address which is monitored on a daily basis. Any queries are answered immediately if possible or if a dispute is raised this will be highlighted to a senior colleague for resolution. Typically responses are sent within 3-5 working days
Every statutory report on record
Most recent first.
| Period | Avg days | Outside terms | 61+ days | Filed |
|---|---|---|---|---|
| H1 2026 | 15 | 2% | 1% | 29 Apr 2026 |
| H2 2025 | 16 | 5% | 2% | 29 Oct 2025 |
| H1 2025 | 14 | 3% | 2% | 30 Apr 2025 |
| H2 2024 | 15 | 2% | 2% | 31 Oct 2024 |
| H1 2024 | 13 | 2% | 2% | 30 Apr 2024 |
| H2 2023 | 14 | 1% | 3% | 31 Oct 2023 |
| H1 2023 | 17 | 2% | 3% | 2 May 2023 |
| H2 2022 | 16 | 2% | 2% | 1 Nov 2022 |
| H1 2022 | 15 | 1% | 2% | 29 Apr 2022 |
| H2 2021 | 15 | 1% | 2% | 3 Nov 2021 |
On the public register · Companies House
Company record
- Status
- Active
- Type
- PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)
- Incorporated
- 24 Feb 2012
- Registered office
- 12TH FLOOR TOWER WING B, LONDON, SE1 9RT
Quick answers · Cell Therapy Catapult Limited
Are they getting slower or faster?
What's their typical pay point?
Can I see what this means for my invoices?
Stay ahead
Watch Cell Therapy Catapult Limited (free)
Their next payment report is due ≈ 27 Oct 2026. We watch their public record and email you when something changes — a new payment report, late filings, insolvency markers, new charges.
You’ll get a confirmation email first. Unsubscribe any time. How we handle your address.
More large companies in professional & technical services
CD&R Firefly Bidco Limited · Celltech R&D Limited · Ccep Group Services Limited · Centaur Services Limited · Catalyst Healthcare (Manchester) Limited · Centre for Process Innovation Limited
How UK payment reporting works
What is a Payment Practices Report?
What does "paid outside agreed terms" mean?
How often is this data updated?
Is this official government data?
How this is compiled. Built from official records only: Companies House and the gov.uk payment-practices service. The payment figures are self-reported — companies over the size threshold must file them by law and the board signs them off. No credit-agency data. The numbers are theirs; the plain-English read is ours. This is information compiled from public records under the Open Government Licence v3.0 — not a credit rating and not advice.
The 31-day comparison figure is the median across 6,104 companies with a current statutory report — every sector pooled, not an average of sector medians (how the figure is built).
Report PL-07964711 · latest period to 31 Mar 2026
Built by YORXEN LTD · registered in England & Wales · CRN 17303256 · privacy · terms.